SynthesisBMC musculoskeletal disorders2026
Femoral component sagittal alignment and its influence on short-term outcomes in total knee arthroplasty: a systematic review.
Synthesis in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeVariations in femoral component sagittal alignment may influence clinical outcomes and survival rates following primary total knee arthroplasty (TKA). This study aims to systematically review the influence of femoral component sagittal alignment on short-term outcomes (≥ 6-month follow-up) and potentially characterize an optimal orientation.
methodsA systematic review was carried out following the PRISMA guidelines to identify studies in PubMed, Cochrane Library, and SPORTDiscus with Full Text databases between January 2010 and April 2025. Eligible studies included adults undergoing primary TKA, quantified sagittal femoral component alignment, and reported at least one of the following outcomes with ≥ 6 months follow-up: patient-reported outcome measures (PROMs), range of motion (ROM), anterior knee pain, or revision/survivorship. Studies not stratifying outcomes by sagittal angle were excluded. After screening 2137 initial results, 10 studies met inclusion and exclusion criteria, with 9 being prospective/retrospective cohort studies and 1 Randomized Control Trial (RCT). Data extraction included study design, demographics, implant type, imaging/measurement method, sagittal alignment definitions, PROMs, ROM, and revision rates. Due to heterogeneity in alignment grouping and outcome reporting, a narrative synthesis was performed rather than a meta-analysis.
resultsTen studies comprising 5,205 TKAs were included, with two robotic-assisted TKA cohorts and eight manual TKA cohorts. Mild flexion of the femoral component was frequently associated with improved short-term outcomes, but results differed by measurement method and outcome definition. Five of eight studies evaluating functional scores and five of six studies evaluating ROM reported improved outcomes with mild flexion compared with neutral or extended alignment. Only two studies explored failure rate, while anterior knee pain was only reported by one study.
conclusionsAcross studies evaluating sagittal alignment in primary TKA, mild flexion of the femoral component was more commonly associated with improved functional outcomes, ROM, implant survival, and pain compared with neutral or extended alignment. However, these associations were inconsistent, and certainty of evidence was generally low or very low for most outcomes, indicating additional RCTs with standardized femoral flexion angle groupings and outcome measurements are needed to further investigate optimal sagittal component positioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.